NRX-2085

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameNRX-2085
Drug Alias NameNRX-2085
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate [NMDA] receptor modulatorsGlutamate [NMDA] receptor partial agonists
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsSchizophrenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNaurex Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNaurex Inc
Active IndicationsN/A
Inactive IndicationsSchizophrenia

Other Information

ATC CodeN/A
Related LinksN/A